Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn @ASCO @JCO_ASCO @JCOOP_ASCO #ArtificialIntelligence #CancerResearch #CancerCare #MedTech #DigitalHealth #AI https://t.co/6w4Nc1tT1O
Artificial intelligence in oncology.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2022 – Nov 2025Where it's discussed
-
X / Twitter102 posts
-
Bluesky15 posts
-
YouTube2 videos
AI synopsis
What people are saying
The overall digital discussions reveal a strong consensus that AI is revolutionizing oncology, with examples like references to clinical trials and research symposia illustrating active engagement; the tone is optimistic and forward-looking, emphasizing AI’s potential to improve diagnostics and patient outcomes.
Most discussions highlight the promise and positive impact of AI in oncology, reflecting a consensus on its benefits for cancer care.
The discussions consistently emphasize evolving roles, future potential, and ongoing research, indicating high interest.
Posts reference specific studies, conferences, and applications, showing thoughtful participation and depth of engagement.
Multiple mentions of AI transforming diagnostics, treatment, and research demonstrate the perceived high impact of AI in this field.
Abstract in brief
- Artificial intelligence (AI), especially deep learning, has significantly advanced cancer research and healthcare over the past decade by solving complex problems and improving diagnostics.
- Recent examples show AI's ability to address previously unsolvable issues in oncology, but there are still challenges and obstacles to widespread adoption that need to be addressed.
- The review also highlights useful resources and datasets that can help researchers harness AI's potential, predicting that AI-driven innovations will lead to major insights in oncology in the next ten years.]
Top posts
Most liked on X and BlueskyAt our #AACR25 Exhibitor Spotlight Theater, Ryan Fukushima, Chief Operating Officer at Tempus, and Robert Shoemaker, Ph.D., Senior Vice President of Research at Erasca, Inc., spoke about the transformative power of artificial intelligence in oncology research and drug https://t.co/PggSW8L10i
At the #AACR25 Methods Workshop on Applications of AI and Natural Language Processing? Read more in session chair @VanAllenLab's recent review in @CD_AACR: Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions https://t.co/PV3UIwvezV https://t.co/xSaytrgKt9
From improving efficiency to advancing research, AI is transforming oncology. I joined @Shepard Dale on the @CleClinicMD Cancer Advances podcast to discuss what this means for patients and providers. #CleClinicCancer https://t.co/5j7lBYFQkQ
Elizabeth McKenna highlights Eli Van Allen’s review on artificial intelligence in oncology @ElizSMcKenna @VanAllenLab @CD_AACR https://t.co/qgouk8eMkd #Cancer #Medicine #Health #AACR25 #MedX #MedNews #MedEd #ArtificialIntelligence #Oncology #OncoDaily https://t.co/L04xiidQaP
The AACR Special Conference on Artificial Intelligence and Machine Learning opens this evening with a keynote lecture from Dana Pe’er. The conference will offer a comprehensive exploration of the transformative role of artificial intelligence in oncology. #AACRai25 https://t.co/KtA0BXumAA
All mentions
AI-Driven Target Discovery in Therapeutic Development
This video discusses the integration of AI in bridging the gap between benchside research and bedside application, focusing on accelerated target discovery and therapeutic development. Highlighted research includes…
AI-Driven Approaches for Cancer Diagnosis in Histopathology
This video explores AI and deep learning methods applied to histopathological cancer diagnosis. It discusses how artificial intelligence enhances diagnostic accuracy, enabling precision oncology and highlighting…
RT @ASCOPost: AI can complement oncologists and allow them to take cancer care to new heights, doing more and better work rather than just…
AI can complement oncologists and allow them to take cancer care to new heights, doing more and better work rather than just replacing them, according to @JRChen_IHCAMS & Robert Peter Gale, MD, PhD #AIinHealthcare https://t.co/jcjzUtZzyd https://t.co/cbPZznctcI
New Research: Artificial intelligence in oncology: promise, peril, and the future of patient–physician interaction https://t.co/YTWeoevPUS #FrontiersIn #DigitalHealth
RT @ElinardouHelena:
RT @ElinardouHelena:
"Physician-complementing AI empowers skilled physicians to do more and makes them even better at what they do. -JUNREN CHEN, MD, PhD, AND ROBERT PETER GALE, MD, PhD" https://t.co/8qYkMQDGzz via @ascopost
Precision medicine and beyond: Evolving roles of targeted therapy, immunotherapy, and artificial intelligence in oncology https://t.co/BKSwhQR9eK
RT @manigreeva: "Artificial intelligence in oncology" My two cents. Please share your take/critique @manojpandey66 @sankha_shubhra @dr_kat…
RT @manigreeva: "Artificial intelligence in oncology" My two cents. Please share your take/critique @manojpandey66 @sankha_shubhra @dr_kat…
"Artificial intelligence in oncology" My two cents. Please share your take/critique @manojpandey66 @sankha_shubhra @dr_kataki @amitavb1 @abandopa https://t.co/wAFidxlnpD
"Artificial intelligence in oncology" My two cents. Please share your take/critique @manojpandey66 @sankha_shubhra @dr_kataki @amitavb1 @abandopa https://t.co/wAFidxlVfb
Head to Pacific Ballroom for an #ITSOS2025 keynote speech and Industry roundtable discussion focused on the emerging role of Artificial Intelligence in Oncology Clinical Trials, featuring speakers from @Merck, @AstraZeneca, and @bmsnews.
Revolutionizing Cancer Care: The Growing Impact of Artificial Intelligence in Oncology https://t.co/jXyCK6kVfF
How is AI reshaping cancer care? @jamecancerdoc joins the @CleClinicMD Cancer Advances podcast to share insights on real-world applications, clinical trials, and the future of oncology. #CleClinicCancer https://t.co/TF9hvD75ga
From improving efficiency to advancing research, AI is transforming oncology. I joined @Shepard Dale on the @CleClinicMD Cancer Advances podcast to discuss what this means for patients and providers. #CleClinicCancer https://t.co/5j7lBYFQkQ
RT @BMJOncology:
RT @BMJOncology:
RT @BMJOncology:
Register for this free symposium, organised by the Multi R Project, bringing together leading researchers, clinicians, industry experts and patient advocates to explore the transformative potential of artificial intelligence in oncology
Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”! @phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social will discuss about how AI is transforming #oncology.
Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”! @phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social are proud to discuss how AI is transforming #oncology.
IOWG - The Future of Artificial Intelligence in Oncology @ChangUCanSpare https://t.co/Nx27jEEaWO #OncoDaily #Oncology #Cancer #Health #Medicine #IOWG #MedX https://t.co/IZPvrQz26h
RT @DrAlbertJonesau: Practical Use of Artificial Intelligence in Oncology and Genetics by @DigitalMehmet https://t.co/814iuKDZpn
Practical Use of Artificial Intelligence in Oncology and Genetics by @DigitalMehmet https://t.co/814iuKDZpn
Practical Use of Artificial Intelligence in Oncology and Genetics by @DigitalMehmet https://t.co/EsLvd0Toew
Practical Use of Artificial Intelligence in Oncology and Genetics by @DigitalMehmet https://t.co/r1LlN9Sc12
Integrative Oncology Working Group (IOWG) - Upcoming Grand Rounds on the Future of Artificial Intelligence in Oncology @AnthonyChangMD https://t.co/0loQlAUSa7 #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #IOWG #GrandRounds https://t.co/4qynOQDnr9
RT @TempusAI: At our #AACR25 Exhibitor Spotlight Theater, Ryan Fukushima, Chief Operating Officer at Tempus, and Robert Shoemaker, Ph.D., S…
RT @TempusAI: At our #AACR25 Exhibitor Spotlight Theater, Ryan Fukushima, Chief Operating Officer at Tempus, and Robert Shoemaker, Ph.D., S…
RT @TempusAI: At our #AACR25 Exhibitor Spotlight Theater, Ryan Fukushima, Chief Operating Officer at Tempus, and Robert Shoemaker, Ph.D., S…
At our #AACR25 Exhibitor Spotlight Theater, Ryan Fukushima, Chief Operating Officer at Tempus, and Robert Shoemaker, Ph.D., Senior Vice President of Research at Erasca, Inc., spoke about the transformative power of artificial intelligence in oncology research and drug https://t.co/PggSW8L10i
Global Artificial Intelligence in Oncology Market Size to Hit USD 2,145.1 Million by 2025, grow at a CAGR of 33.7% | Coherent Market Insights https://t.co/2QiU0ZgiHr #Business #HealthMedicine #PharmaceuticalsBiotech #World https://t.co/CRceH8Q3S0
RT @AACR: The AACR Special Conference on Artificial Intelligence and Machine Learning opens this evening with a keynote lecture from Dana P…
RT @AACR: The AACR Special Conference on Artificial Intelligence and Machine Learning opens this evening with a keynote lecture from Dana P…
RT @AACR: The AACR Special Conference on Artificial Intelligence and Machine Learning opens this evening with a keynote lecture from Dana P…
The AACR Special Conference on Artificial Intelligence and Machine Learning opens this evening with a keynote lecture from Dana Pe’er. The conference will offer a comprehensive exploration of the transformative role of artificial intelligence in oncology. #AACRai25 https://t.co/KtA0BXumAA
RT @AACR: .@AACR_CEO Margaret Foti and #18ICML Organizing Committee Chair Francesco Bertoni co-chaired the AACR-ICML Joint Session on "The…
AACR CEO Margaret Foti and #18ICML Organizing Committee Chair Francesco Bertoni co-chaired the AACR-ICML Joint Session on "The Role of Artificial Intelligence in Oncology" today at the International Conference on Malignant Lymphoma in Lugano. @frbertoni.bsky.social @icmlugano.bsky.social
.@AACR_CEO Margaret Foti and #18ICML Organizing Committee Chair Francesco Bertoni co-chaired the AACR-ICML Joint Session on "The Role of Artificial Intelligence in Oncology" today at the International Conference on Malignant Lymphoma in Lugano. @icmlugano @frbertoni https://t.co/AHmthZGjpZ
RT @jmirpub: #CallForPapers
RT @jmirpub: #CallForPapers
Discover how Artificial Intelligence is revolutionizing oncology with innovative cancer diagnostics and personalized therapy. Dive into our comprehensive article on Human-AI collaboration in cancer care.
RT @jmirpub: #CallForPapers
At #ASCO25 today, Alex Pearson, MD, PhD, member of our SAB will present on the future of AI in oncology - be sure to check out this timely talk! Implications of Artificial Intelligence in Oncology: Training and Education of Current Faculty Room S501 7:30–9:30 AM | Education https://t.co/KgaScpAKXk
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @BMJOncology: Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients Understanding and priorit…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @jmirpub: #CallForPapers
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @BMJOncology: Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients Understanding and priorit…
RT @BMJOncology: Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients Understanding and priorit…
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients Understanding and prioritizing the needs of the stakeholders will foster the development of impactful AI tools https://t.co/Jteuo3FImj
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
RT @RyanNipp: Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn…
Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #ArtificialIntelligence #CancerResearch #CancerCare #MedTech #DigitalHealth #AI
Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. https://t.co/pUZhMntmXn @ASCO @JCO_ASCO @JCOOP_ASCO #ArtificialIntelligence #CancerResearch #CancerCare #MedTech #DigitalHealth #AI https://t.co/6w4Nc1tT1O
RT @ElizSMcKenna: At the #AACR25 Methods Workshop on Applications of AI and Natural Language Processing? Read more in session chair @VanAll…
RT @oncodaily: Elizabeth McKenna highlights Eli Van Allen’s review on artificial intelligence in oncology @ElizSMcKenna @VanAllenLab @CD_AA…
RT @ElizSMcKenna: At the #AACR25 Methods Workshop on Applications of AI and Natural Language Processing? Read more in session chair @VanAll…
Elizabeth McKenna highlights Eli Van Allen’s review on artificial intelligence in oncology @ElizSMcKenna @VanAllenLab @CD_AACR https://t.co/qgouk8eMkd #Cancer #Medicine #Health #AACR25 #MedX #MedNews #MedEd #ArtificialIntelligence #Oncology #OncoDaily https://t.co/L04xiidQaP
RT @ElizSMcKenna: At the #AACR25 Methods Workshop on Applications of AI and Natural Language Processing? Read more in session chair @VanAll…
RT @jmirpub: #CallForPapers
At the #AACR25 Methods Workshop on Applications of AI and Natural Language Processing? Read more in session chair @VanAllenLab's recent review in @CD_AACR: Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions https://t.co/PV3UIwvezV https://t.co/xSaytrgKt9
RT @jmirpub: #CallForPapers
RT @jmirpub: #CallForPapers
RT @jmirpub: #CallForPapers
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice ascopubs.org/doi/10.1200/...
RT @jmirpub: #CallForPapers
RT @jmirpub: #CallForPapers
RT @jmirpub: #CallForPapers
Artificial Intelligence in Oncology Market Trends and Forecasts Report 2024-2035 with Discussions with https://t.co/KcLMWpPpjr, Nucleai, Visiopharm, Enlitic - https://t.co/guyiBA7QmK https://t.co/a2k25wleZl https://t.co/eC3h0ypdW4
#ArtificialIntelligence in #Oncology #Research Report 2024-2035: Global Market to Grow by $8 Billion as a CAGR of 21.4% - Industry Stakeholders are Actively Upgrading their Existing #AI Capabilities. https://t.co/maTTbfolvz #innovation #innovationecosystems #technology
RT @AshishJ79894328: Check out this research output at Maastricht University: Quantitative imaging and artificial intelligence in oncology…
RT @jmirpub: #CallForPapers
RT @jmirpub: #CallForPapers
Opportunities for Artificial Intelligence in Oncology #oncology #cancer #IA #patients https://t.co/a6LRa6tPf8
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice https://t.co/22aODqdVyi
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients https://t.co/Cym9aTti4G via @anantm et al https://t.co/VU2glrUAU4
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients ascopubs.org/doi/10.1200/... #JCOOP #AI
RT @CD_AACR: Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions by Eli Van Allen et al. https://t.co…
RT @CD_AACR: Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions by Eli Van Allen et al. https://t.co…
RT @CD_AACR: Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions by Eli Van Allen et al. https://t.co…
RT @CD_AACR: Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions by Eli Van Allen et al. https://t.co…
Global Artificial Intelligence in Oncology Market Witnessing https://www.europesays.com/1909000/ Global Artificial Intelligence in Oncology Market The Global Global Artificial Intelligence in Oncology Market is expected to grow…
explainable artificial intelligence in oncology. [7/7 of https://arxiv.org/abs/2502.17503v1]
Reminder>> Artificial Intelligence in #Oncology #Research: Applications, Challenges, and Future Perspectives (preprint) #openscience #PeerReviewMe #PlanP
Reminder>> Artificial Intelligence in #Oncology #Research: Applications, Challenges, and Future Perspectives (preprint) #openscience #PeerReviewMe #PlanP
Artificial Intelligence in #Oncology #Research: Applications, Challenges, and Future Perspectives (preprint) #openscience #PeerReviewMe #PlanP
Artificial Intelligence in #Oncology #Research: Applications, Challenges, and Future Perspectives (preprint) #openscience #PeerReviewMe #PlanP
Artificial Intelligence in Oncology Market Expected to Boom to US$ 11.52 Billion by 2030 #USA #Artificial_Intelligence #Delray_Beach #cancer_detection #Oncology_Market
Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice - The Lancet Regional Health – Europe www.thelancet.com/journals/lan...
New video from "TMDU Research Activities 2022-2023" has been released. “Filling the Gap Between Benchside and Bedside: AI-accelerated Target Discovery to Therapeutic Development” by Hideyuki Shimizu. Please take a look! YouTube: https://t.co/TtFTlqVPY7 #東京医科歯科大学 #tmdu https://t.co/G31DaJRrnt
Artificial intelligence in oncology: https://t.co/3WcBBHuFAN #artificialintelligence #oncology
RF
T
EM
JF
O
A
SK
TP
FH
SC
NR
HL
JP
US
ST
AF
DK
A
II
KR
GB
CT
O
BO
J
DY
DJ
AM
DB
MM
ML
MF
A
BK
YH
AS
BD
H
NB
OC
MP
BC
P
OD
CW
BM
RC
ND
AD
AK
SP
PB
IK
BM
SK
DA
AD
SF
AT
M
FC
YS
RS
DB
PC
CF
KA
KH
TM
CR
LG
US
N
WS
JC
CM
C
LW
EA
JO
CW
CA
AJ
MS
G
G
C
AP
S
SM
AC
L